A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability and Pharmacological Effects of PT00114 in Healthy Volunteers
PT00114-001A
Phase 1 other active
Quick answer
A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability and Pharmacological Effects of PT00114 in Healthy Volunteers for Phase I study in healthy male and female volunteers. Intended indication: mood disorders is a Phase 1 program (other) at Protagenic Therapeutics, Inc.new with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protagenic Therapeutics, Inc.new
- Indication
- Phase I study in healthy male and female volunteers. Intended indication: mood disorders
- Phase
- Phase 1
- Modality
- other
- Status
- active